This protocol is judged by an institutional assessment board, an independent team that reviews any scientific trials involving human beings. If a study requires a Timetable I drug, as soon as the board approves the protocol as moral, the researchers must submit an application for an investigational new drug (IND) amount from the FDA.Weiser urged so